ユーグレナ ヘルスケアラボ

多言語
language

Euglena research reports

  • euglena
  • lifestyle disease
2017.09.29

Ingestion of Euglena or paramylon prevented nonalcoholic steatohepatitis (NASH)-associated liver fibrosis in mice

Liver fibrosis in model mice, with induced NASH, was suppressed after eating a diet containing Euglena and paramylon powders for 27 days. This result suggests that the Euglena and paramylon powders effectively suppressed disease progression.

What is NASH?

Steatohepatitis, when it is not obviously caused by alcohol, is called nonalcoholic fatty liver disease (NAFLD), and its extreme form, which can potentially lead to cirrhosis and liver cancer, is called NASH. There is currently no effective therapy for NASH, but finding a method to suppress the progression of liver fibrosis is believed to be the key to the prevention of the disease progression into liver cancer. Fibrosis is an abnormal proliferation of connective tissue in internal organs.

back to list
ページトップへ